Drug Manufacturing Sector Scorecard – Thematic Intelligence
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Pharma supply chains are complex processes through which drugs are developed, manufactured, and delivered to patients. Additionally, outsourced manufacturing is a key supply chain component which is primarily driven by increased drug consumption and the development of more advanced treatments. Therefore, pharma companies are under increasing pressure to ensure supply chain sustainability and resilience. Environmentally sustainable supply chains and manufacturing involve reducing greenhouse gases, improving air quality and water management, and more renewable energy usage. Social sustainability ensures that patients get access to drugs and promotes employee health and safety, human rights, and ethics.
The drug manufacturing thematic scorecard report provides a top-down, comprehensive outlook for key players in the drug manufacturing sector over the next two to four years.
Drug Manufacturing – Theme Map
GlobalData’s theme map for the biopharmaceutical industry covers industry-specific themes, disruptive technologies, and macroeconomic and regulatory themes. Some of the themes in the map will significantly impact companies in a particular sector over the coming year, but all of them will be important over the next five to 10 years.
This map highlights the current themes that are driving share prices and reflects an up-to-date view of the major issues impacting the industry. These themes are selected and updated based on internal expertise of the biopharmaceutical industry and client feedback.
Drug Manufacturing – Theme Map
For more insights on the pharma theme map, download free report sample.
Drug Manufacturing Sector Scorecard
The scorecard includes 51 companies from across the industry, including biopharmaceutical companies, biosimilar and generic manufacturers, and contract development and manufacturing organizations (CDMOs).
GlobalData’s drug manufacturing scorecard includes the 10 most important themes driving the future performance of pharma manufacturing over the next two to four years. They are:
- Supply Chain Management
- Big data
- AI
- Cloud Computing
- Cybersecurity
- Blockchain
- ESG
- Robotics
- Foreign Direct Investment (FDI)
- Deal Making
Supply Chain Management
Pharma supply chains are complex, multi-step processes through which drugs are developed, manufactured, and delivered to patients. Ineffective supply chains can impact patients’ health, customer satisfaction, company reputation, and profits.
Outsourcing drug manufacturing is a key component of pharma supply chains. The increase in outsourced manufacturing is driven by increased healthcare demand and drug consumption, increased demand for biosimilars and generics, and the development of advanced treatments, such as cell and gene therapies drive outsourcing. Pharma companies are increasingly using the expertise of dedicated CDMOs to outsource drug manufacturing. In addition, many large pharma companies also provide excess capacity manufacturing to other companies.
Furthermore, recent geopolitical events are causing the pharma industry to consider its supply chain more carefully than ever. Highly developed pharma markets rely on foreign suppliers for drugs and active pharmaceutical ingredients (APIs), especially China and India.
Drug Manufacturing Sector Scorecard – Thematic Screen
For more sector scorecard insights, download free report sample.
Scope:
- GlobalData’s Drug Manufacturing Thematic Scorecard report provides a top-down, comprehensive future outlook for key players in the drug manufacturing sector over the next two to four years.
- These themes are Supply Chain Management, Foreign Direct Investment (FDI), Deal Making, ESG, Robotics, AI, Big Data, Cloud Computing, Cybersecurity, and Blockchain
- The scorecard includes 51 companies from across the industry, including biopharmaceutical companies, biosimilar and generic manufacturers, and contract development and manufacturing organizations (CDMOs).
- It is important to note that this scorecard is not an assessment of current performance of a company in a theme, but a view of future performance based on current levels of activity and investment.
- The methodology section contains information on what data sources were used to generate the thematic scores for each company.
- The scorecard is live on the PIC and will be updated quarterly.
Reasons to Buy
- Identify the key drug manufacturing themes for the next 2-4 years and learn how they will impact the market.
- Understand which key themes should be addressed to drive share price.
- Understand which companies are best positioned for success within critical themes and why.
- Learn which companies have underinvested in key themes and are most vulnerable to disruption.
- Help companies adapt their strategy to anticipate and benefit from these themes as they play out.
- Help identify future winners and losers in drug manufacturing to inform partnership strategies.
Merck & Co Inc
AstraZeneca Plc
Bristol-Myers Squibb Co
Pfizer Inc
Johnson & Johnson
Boehringer Ingelheim
F. Hoffmann-La Roche Ltd
Novartis AG
GSK Plc
Bayer AG
Eli Lilly and Co
AbbVie Inc
Merck KGaA
Novo Nordisk AS
Catalent Inc
Gilead Sciences Inc
Thermo Fisher Scientific Inc
Astellas
Biogen Inc
Cipla Ltd
Lonza Group Ltd
Amgen Inc
Daiichi Sankyo Co Ltd
Vertex Pharmaceuticals Inc
WuXi AppTec Co Ltd
Charles River Laboratories International Inc
CSL Ltd
Reliance Life Sciences Pvt Ltd
Sanofi
Innovent Biologics Inc
Otsuka
Teva Pharmaceutical Industries Ltd
UCB
Dr. Reddy's Laboratories Ltd
Regeneron Pharmaceuticals Inc
Samsung Biologics
Sun Pharmaceutical Industries Ltd
Biocad
Cadila Pharmaceuticals Ltd
Celltrion Inc
Coherus BioSciences Inc
CSPC Pharmaceutical Group Ltd
Generium
Intas Pharmaceuticals Ltd
Lupin Ltd
Perrigo Co Plc
Seagen Inc
Shanghai Henlius Biotech Inc
Viatris Inc
Zydus Lifesciences
Table of Contents
Frequently asked questions
-
What are the top 10 themes shaping the drug manufacturing industry?
Supply Chain Management, Big Data, AI, cloud computing, cybersecurity, blockchain, ESG, robotics, Foreign Direct Investment (FDI), and deal making are the top 10 themes shaping the drug manufacturing industry.
-
Where should pharma companies ideally invest to secure the drug manufacturing industry?
Pharma companies must invest in smart technologies for more efficient and secure drug manufacturing.
-
What are some of the biggest themes driving growth in the biopharmaceuticals industry?
Geopolitics, demographic changes, empowered patient, and AI are some of the key themes driving growth in the biopharmaceuticals industry.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.